Detalhe da pesquisa
1.
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.
Mol Ther
; 29(2): 611-625, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160073
2.
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Lancet Oncol
; 23(7): 833-835, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483383
3.
Alphavirus-based vaccines encoding nonstructural proteins of hepatitis C virus induce robust and protective T-cell responses.
Mol Ther
; 22(4): 881-90, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24370701
4.
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
Lancet Infect Dis
; 23(8): 901-913, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088096
5.
Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas.
Int J Cancer
; 131(8): 1828-36, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22287095
6.
Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma.
Gynecol Oncol
; 126(3): 474-80, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22668882
7.
SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Transplant Direct
; 8(11): e1387, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284929
8.
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs.
Oncoimmunology
; 10(1): 1898753, 2021 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796407
9.
Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?
Ther Adv Vaccines Immunother
; 7: 2515135519874677, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31620673
10.
Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens.
Oncoimmunology
; 7(10): e1487913, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288352
11.
A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development.
Oncoimmunology
; 4(10): e1029699, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26451295